glp 1 agonist therapy GLP-1 Agonists: A Comprehensive Overview Metabolic Flux Adaptations During GLP-1

Back Lasker Foundation (2024) 'GLP-1-based therapy for obesity'

Moreover, the suppression of cardiac inflammation, fibrosis and hypertrophy with GLP-1RA treatment provide a clinically favorable impact on cardiac dysfunction

Patients with Significant Liver Involvement: Those diagnosed with hepatic steatosis (fatty liver) or early-stage MASH, due to the potent anti-fat effects of the glucagon component on the liver

[DOI] [PubMed] [Google Scholar] 476.Gromada J., Ding W.G., Barg S., Renstrom E., Rorsman P

Further clinical trials and experience will help improve our understanding of the benefits of this drug

Type 2 diabetesmarked by insulin resistance and disrupted glucose metabolismposes one of the most pressing public health challenges